Related Experiment Video
Updated: Oct 26, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[MIA 2021, Comprehensive Asthma Management. Guidelines for Mexico]
Désireeé Larenas-Linnemann1, Jorge Salas-Hernández, Blanca E Del Río-Navarro
1Fundación Clínica Médica Sur, Ciudad de México, México. marlar1@prodigy.net.mx.
This study developed Comprehensive Asthma Management (MIA) guidelines for Mexico, offering evidence-based strategies for diagnosis and treatment. The MIA platform ensures updated asthma care tailored to local needs.
Area of Science:
- Pulmonology
- Allergology
- Clinical Guideline Development
Background:
- Asthma is a prevalent chronic respiratory disease requiring updated management strategies.
- International guidelines for asthma diagnosis and treatment have been recently revised.
Purpose of the Study:
- To establish a national platform for evidence-based asthma management guidelines in Mexico.
- The platform is named Comprehensive Asthma Management (MIA).
Main Methods:
- Utilized the ADAPTE methodology for guideline development.
- Involved a multidisciplinary expert group and representatives from 13 institutions.
- Reviewed international guidelines (GINA, GEMA, BTS/SIGN, ATS/ERS) and formulated key clinical questions.
Main Results:
- Developed evidence-based responses considering safety, cost, and local context.
- Achieved consensus through a Delphi process involving the MIA development group.
Conclusions:
- Generated a comprehensive document with figures and algorithms for asthma management in Mexico.
- The guidelines are tailored to local realities and supported by multiple professional societies.
- Acute asthma management is not covered in this document.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:

